Dr. Eric Kaoru Nakakura, MD

Dr. Nakakura practices at Sutter Infusion & Pharmacy Services in Fairfield, California.

Dr. Nakakura's NPI, 1033173943, was assigned on April 17, 2006. Dr. Nakakura graduated from Stanford University School Of Medicine in 1995. Dr. Nakakura holds California license A88496.

Dr. Nakakura's primary practice is Sutter Infusion & Pharmacy Services, at 4830 Business Center Dr, Fairfield, CA 94534 in Solano County. The practice phone is (510) 450-8900.

Dr. Nakakura's primary practice is Sutter Infusion & Pharmacy Services in Fairfield, California. Dr. Nakakura is also affiliated with UCSF Helen Diller Medical Center at Parnassus Heights. The medical group on file is Ucsf Dept Of Surgery. Dmand AI also links Dr. Nakakura to 2 more hospitals, 2 group practices and clinics, 2 medical groups and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nakakura practices, 6 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Nakakura's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Nakakura is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Nakakura's licenses on file in 2 states: California and Maryland.

Dmand AI lists abdominal adhesion surgery and colon removal among the conditions Dr. Nakakura treats.

CMS data shows 282 Medicare services from Dr. Nakakura across 6 procedure codes in 2024, for 224 Medicare patients. Medicare paid $17,071 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 224 Medicare patients who saw Dr. Nakakura in 2024. The largest group is 65 to 74, with 121 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nakakura's median patient age at 68, with 50% women.

In 2024, Dr. Nakakura wrote 37 Medicare Part D claims for 14 patients. 46% of them were for generic drugs. CMS names the drug for 16 of them, across 1 drug with 11 or more claims each, at $23,063 in total drug cost. In 2022, CMS named 20 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Nakakura for performance year 2024, reported as part of a group. Dr. Nakakura accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nakakura as offering telehealth.

Dmand AI links 88 papers to Dr. Nakakura, published from 2001 to 2025. 2024 was the busiest year, with 12. The most frequent topics are Neuroendocrine Tumors, Pancreatic Neoplasms and Liver Neoplasms. Dr. Nakakura has published most often in Ann Surg Oncol. Dr. Nakakura's most frequent co-authors are Emily K. Bergsland, MD, Carlos Uriel Corvera, MD and Kenzo Hirose, MD.

CMS Open Payments shows 6 general payments to Dr. Nakakura from 4 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $140.

Dmand AI lists 5 awards for Dr. Nakakura, most recently America's Top Doctors in 2014.

Dr. Nakakura graduated from Stanford University School Of Medicine in 1995. Dr. Nakakura is a member of ACS.

Dr. Nakakura is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.